AfshinEliGabayanMD

Physician

Dr. Gabayan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8900 Wilshire Blvd
Beverly Hills, CA 90211
Phone+1 310-432-8900

Fax+1 310-432-8901

Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1994 - 1997
Keck School of Medicine of the University of Southern CaliforniaClass of 1994

PubMed

148 citations
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.
Alexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, Nizar J Bahlis, H Miles Prince
Nature Medicine. 2023-09-01
33 citations
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors
Gregory L. Beatty, Safi Shahda, Thaddeus Beck, Nikhil Uppal, Steven J. Cohen
The Oncologist. 2019-01-01
35 citations
Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma
Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber Camacho, David Irwin
British Journal of Haematology. 2009-09-01

Kiromic BioPharma Partners with Beverly Hills Cancer Center for Groundbreaking Lung Cancer Study, USOctober 24th, 2023
Kiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial AgreementOctober 25th, 2023
Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerJanuary 30th, 2024
Join now to see all